The high view across every trial.

Trial data rolls up to the portfolio level — across trials, phases, assets, programs, geographies, and therapeutic areas. See critical performance metrics at a glance, then drill to the study, site, subject, or vendor driving the issue.

Request Demo Vivo for Portfolio Leadership

Portfolio Intelligence

Analyze your portfolio across all your trials.

Vivo helps clinical development leaders move beyond study-by-study updates into portfolio-level intelligence — built up from the same governed trial-level records, not a separate reporting layer that drifts out of date.

Which studies carry the highest execution risk
Which sites or vendors are creating issues across programs
Which trials show worsening data quality trends
Which milestones are under pressure
What changed across the portfolio since the last review

Portfolio Risk View

Study OS-204 · Oncology Phase 2 High Risk

Study CNS-107 · Alzheimer's Phase 2 Medium Risk

Study IMM-033 · I&I Phase 3 On Track

Study RD-019 · Rare Disease Phase 2 On Track

4 active studies · 2 need attention · Last updated 3h ago

In the Product

The portfolio, in the product.

Vivo Clinical Portfolio site startup view comparing regions, countries, sites, and activation-to-first-patient-in across three studies — Startup posture across every study — plan vs. actual, at a glance. Demonstration portfolio, synthetic data.

From Trial Records to Portfolio Answers

Site, country, and regional profiles — from the portfolio screens down.

Because the portfolio view is built from governed trial-level records, every roll-up can be unrolled: portfolio → program → study → site → subject → source record.

Cross-trial metrics at a glance

Enrollment, data quality, safety, milestones, and vendor performance compared across every active study.

Site & regional profiles

Enable site, country, and regional profiles directly from portfolio screens — who performs, where, across which programs.

Portfolio-level Ask Vivo

"Which studies have the highest execution risk this month?" — asked once, answered across the portfolio, evidence attached.

Portfolio intelligence also closes the loop with site intelligence & trial planning: every completed trial enriches the mastered site records your next plan is built on.